PDCD1 and neoplasm: However, additional functional studies and more specific determinations should be made to accurately address if when applying this combined therapy, the high number of PD-1+ cells is indeed a sign of immunosuppression modulated by its interaction with tumor cells expressing PDL-1 or a contribution to tumor elimination through active cytotoxic lymphocytes.